4//SEC Filing
Cyclacel Pharmaceuticals, Inc. 4
Accession 0001104659-13-089468
$BGMSCIK 0001130166operating
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 5:23 PM ET
Size
5.5 KB
Accession
0001104659-13-089468
Insider Transaction Report
Form 4
McBarron Paul
DirectorEVP, Finance, CFO, COO
Transactions
- Award
Option
2013-12-09+70,000→ 70,000 totalExercise: $4.61Exp: 2023-12-09→ Common Stock (70,000 underlying)
Footnotes (2)
- [F1]These options are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
- [F2]These securities were issued as part of the Issuer's annual equity compensation to executive officers.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001130166
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 5:23 PM ET
- Size
- 5.5 KB